Description
Generic Name: Deferoxamine Mesylate
Pharmacologic Category: Antidote; Chelating Agent
Dosage Form and Strengths:500 mg/Vial lyophilized powder for solution for injection
Indication and Usage: Desfonak is indicated for acute iron toxicity intoxication and chronic iron overload secondary to multiple transfusions (often due to the presence of thalassemia major or sickle cell disease).